BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31747243)

  • 1. Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy.
    Zhang W; Yu M; Xi Z; Nie D; Dai Z; Wang J; Qian K; Weng H; Gan Y; Xu L
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46614-46625. PubMed ID: 31747243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk-Shell Structure Augment Cancer Chemotherapy.
    Nie D; Dai Z; Li J; Yang Y; Xi Z; Wang J; Zhang W; Qian K; Guo S; Zhu C; Wang R; Li Y; Yu M; Zhang X; Shi X; Gan Y
    Nano Lett; 2020 Feb; 20(2):936-946. PubMed ID: 31671946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targetable drug delivery system based on cell membrane camouflaged liposome for enhanced tumor targeting and improved anti-tumor efficiency.
    Duan M; Zhou D; Ke J; Chen Y; Wu W; Li Y; Ren J; Wang L; Zhang Z; Wang C
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113892. PubMed ID: 38581834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intelligent responsive macrophage cell membrane-camouflaged mesoporous silicon nanorod drug delivery system for precise targeted therapy of tumors.
    Li M; Gao X; Lin C; Shen A; Luo J; Ji Q; Wu J; Wang P
    J Nanobiotechnology; 2021 Oct; 19(1):336. PubMed ID: 34689763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanorods for improved oral drug absorption.
    Zheng N; Li J; Xu C; Xu L; Li S; Xu L
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer.
    Yang XY; Zhang JG; Zhou QM; Yu JN; Lu YF; Wang XJ; Zhou JP; Ding XF; Du YZ; Yu RS
    J Nanobiotechnology; 2022 Dec; 20(1):524. PubMed ID: 36496411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chain-Length- and Saturation-Tuned Mechanics of Fluid Nanovesicles Direct Tumor Delivery.
    Dai Z; Yu M; Yi X; Wu Z; Tian F; Miao Y; Song W; He S; Ahmad E; Guo S; Zhu C; Zhang X; Li Y; Shi X; Wang R; Gan Y
    ACS Nano; 2019 Jul; 13(7):7676-7689. PubMed ID: 31187973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
    Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
    Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.
    Ranjan A; German N; Mikelis C; Srivenugopal K; Srivastava SK
    Tumour Biol; 2017 Jun; 39(6):1010428317705517. PubMed ID: 28618969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes.
    Li K; Zhang Y; Chen M; Hu Y; Jiang W; Zhou L; Li S; Xu M; Zhao Q; Wan R
    Int J Nanomedicine; 2018; 13():19-30. PubMed ID: 29296083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
    Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
    BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.
    Yin F; Yang C; Wang Q; Zeng S; Hu R; Lin G; Tian J; Hu S; Lan RF; Yoon HS; Lu F; Wang K; Yong KT
    Theranostics; 2015; 5(8):818-33. PubMed ID: 26000055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shape effects of electrospun fiber rods on the tissue distribution and antitumor efficacy.
    Zhang H; Liu Y; Chen M; Luo X; Li X
    J Control Release; 2016 Dec; 244(Pt A):52-62. PubMed ID: 27170228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.